MASSACESI, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.398
EU - Europa 13.939
AS - Asia 6.962
SA - Sud America 960
AF - Africa 193
OC - Oceania 148
Continente sconosciuto - Info sul continente non disponibili 4
Totale 38.604
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.251
RU - Federazione Russa 4.341
PL - Polonia 4.309
SG - Singapore 1.824
CN - Cina 1.773
IT - Italia 1.585
HK - Hong Kong 1.415
IE - Irlanda 977
BR - Brasile 803
KR - Corea 795
SE - Svezia 719
DE - Germania 494
UA - Ucraina 455
IN - India 307
FI - Finlandia 295
VN - Vietnam 279
GB - Regno Unito 237
FR - Francia 144
JO - Giordania 144
AU - Australia 142
NL - Olanda 108
CH - Svizzera 96
ID - Indonesia 95
CA - Canada 89
TR - Turchia 84
ES - Italia 67
AR - Argentina 59
CI - Costa d'Avorio 55
MA - Marocco 43
MX - Messico 43
BD - Bangladesh 42
EC - Ecuador 37
JP - Giappone 36
SA - Arabia Saudita 31
IR - Iran 30
ZA - Sudafrica 28
BE - Belgio 21
SC - Seychelles 21
AT - Austria 19
PK - Pakistan 19
EG - Egitto 17
IQ - Iraq 15
BJ - Benin 13
CO - Colombia 13
LT - Lituania 13
RO - Romania 12
UY - Uruguay 10
PE - Perù 9
PY - Paraguay 9
CL - Cile 8
CZ - Repubblica Ceca 8
IL - Israele 7
NP - Nepal 7
VE - Venezuela 7
NZ - Nuova Zelanda 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
GR - Grecia 5
KE - Kenya 5
KZ - Kazakistan 5
NO - Norvegia 5
PH - Filippine 5
BH - Bahrain 4
BO - Bolivia 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
KG - Kirghizistan 4
KW - Kuwait 4
MK - Macedonia 4
MY - Malesia 4
AL - Albania 3
HN - Honduras 3
HU - Ungheria 3
LA - Repubblica Popolare Democratica del Laos 3
PA - Panama 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
XK - ???statistics.table.value.countryCode.XK??? 3
IS - Islanda 2
LB - Libano 2
LI - Liechtenstein 2
LK - Sri Lanka 2
LU - Lussemburgo 2
RS - Serbia 2
UG - Uganda 2
AO - Angola 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CY - Cipro 1
DZ - Algeria 1
ET - Etiopia 1
EU - Europa 1
GE - Georgia 1
GH - Ghana 1
HR - Croazia 1
Totale 38.593
Salva come PNG Salva come JPEG
Città #
Warsaw 4.297
Santa Clara 4.076
Fairfield 1.384
Ashburn 1.279
Hong Kong 1.229
Singapore 1.218
Dublin 973
Chandler 869
Seoul 792
Woodbridge 643
Jacksonville 587
Seattle 568
Hefei 529
Cambridge 511
Houston 505
Beijing 464
Wilmington 449
Altamura 343
Lawrence 338
Florence 285
Buffalo 278
Princeton 262
Ann Arbor 256
Los Angeles 242
Boston 223
Mumbai 192
Dallas 183
Kent 161
Moscow 148
Munich 143
Milan 140
Melbourne 127
Boardman 124
Clifton 100
New York 100
Bern 89
San Diego 89
Dearborn 88
Medford 88
Shanghai 88
Rome 85
Turku 78
Jakarta 72
Ho Chi Minh City 71
São Paulo 69
Dong Ket 63
Paris 61
Hanoi 59
Helsinki 57
Abidjan 55
Falls Church 55
Norwalk 49
West Jordan 43
Phoenix 42
Redondo Beach 42
Toronto 38
Casablanca 35
Chicago 35
Barcelona 33
London 33
Brooklyn 32
Bengaluru 31
Yubileyny 30
Lappeenranta 29
Frankfurt Am Main 27
Hillsboro 27
Tokyo 27
Belo Horizonte 26
Chennai 26
Frankfurt am Main 26
Auburn Hills 25
Bremen 24
Rio de Janeiro 23
Verona 22
Amsterdam 20
Denver 20
Porto Alegre 20
Riyadh 20
Brussels 19
Arezzo 18
Naples 18
Stockholm 18
Izmir 17
Montreal 17
Nashville 17
Guangzhou 16
Catania 15
Johannesburg 15
San Francisco 15
Amman 14
Andover 14
Manchester 14
Nuremberg 14
Bologna 13
Cotonou 13
The Dalles 13
Tianjin 13
Modena 12
Poplar 12
Cairo 11
Totale 26.318
Salva come PNG Salva come JPEG
Nome #
Proposal for a New Score-Based Approach To Improve Efficiency of Diagnostic Laboratory Workflow for Acute Bacterial Meningitis in Adults 416
SWI enhances vein detection using gadolinium in multiple sclerosis. 321
K index improves MS diagnosis and supports the differential diagnosis between MS and MS-like syndromes. 303
A linkage analysis of Multiple Sclerosis with candidate region markers in Sardinian and Continental Italian families. 297
Magnetic resonance imaging of experimental autoimmune encephalomyelitis in the common marmoset. 295
A synthetic glycopeptide of human myelin oligodendrocyte glycoprotein to detect antibody responses in multiple sclerosis and other neurological diseases. 295
Increased CXCL10 expression in MS MSCs and monocytes is unaffected by AHSCT 291
Markers of JC virus infection in patients with multiple sclerosis under natalizumab therapy. 290
Azathioprine versus Beta Interferons for relapsing-remitting multiple sclerosis: a multicentre randomized non-inferiority trial. 284
Efficacy and Safety of Extracranial Vein Angioplasty in Multiple Sclerosis: A Randomized Clinical Trial. 281
Active and passively induced experimental autoimmune encephalomyelitis in common marmosets: a new model for multiple sclerosis. 280
The role of prolactin in autoimmune demyelination: suppression of experimental allergic encephalomyelitis by bromocriptine. 279
Fetal striatal grafting slows motor and cognitive decline of Huntington's disease 278
Central vein sign differentiates MS from CNS inflammatory vasculopathies. 274
A 12-month prospective, observational study evaluating the impact of disease-modifying treatment on emotional burden in recently-diagnosed multiple sclerosis patients: The POSIDONIA study 273
The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative. 270
Lysosomal enzymes in experimental allergic encephalomyelitis: time course and evidence of the source. 269
The Italian multiple sclerosis register. 266
Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial. 264
No proinflammatory signature in CD34+ hematopoietic progenitor cells in multiple sclerosis patients. 263
Survey of the italian neurological output in the three years 1989-1991. 261
In healthy primates, circulating autoreactive T-cells mediate autoimmune disease. 252
Experimental allergic encephalomyelitis in Cynomolgus Monkeys: quantitation of T-cell responses in peripheral blood. 250
Effect of Interferon-β1b on Magnetic Resonance Imaging Outcomes in Secondary Progressive Multiple Sclerosis: Results of a European Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial. 241
Efficacy and safety of venous angioplasty of the extracranial veins for multiple sclerosis. Brave dreams study (brain venous drainage exploited against multiple sclerosis): study protocol for a randomized controlled trial 238
Histopathological characterization of magnetic resonance imaging-decectable brain white matter lesions in a primate model of multiple sclerosis. 236
Expression of accessory molecules and cytokines in acute EAE in marmoset monkeys (Callithrix jacchus). 232
The formation of inflammatory demyelinated lesions in cerebral white matter. 231
Immunosuppressive activity of 13-cis retinoic acid and prevention of experimental autoimmune encephalomyelitis in rats. 229
Cyclophosphamide Pulse Therapy after Natalizumab Discontinuation for Multiple Sclerosis: a multicenter study. 223
Trapianto intracerebrale di striato fetale nella malattia di Huntington: un aggiornamento dell'esperienza clinica italiana 221
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension. 220
Operationalizing mild cognitive impairment criteria in small vessel disease: The VMCI-Tuscany Study 217
Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial. 217
Placebo-controlled multicentre randomised trial of Interferon beta-1b in treatment of secondary progressive multiple sclerosis. 213
The “central vein sign” in patients with diagnostic “red flags” for multiple sclerosis: A prospective multicenter 3T study 210
Carbon nanotube scaffolds instruct human dendritic cells: modulating immune responses by contacts at the nanoscale. 209
Next Generation Molecular Diagnosis of Hereditary Spastic Paraplegias: An Italian Cross-Sectional Study 205
Environmental modifiable risk factors for multiple sclerosis: Report from the 2016 ECTRIMS focused workshop 196
HIGH RESOLUTION IMAGING TECHNIQUES OF THE RETINA AND OPTIC NERVE FOR THE ANALYSIS OF MICROSTRUCTURAL AND VASCULAR CHANGES IN MULTIPLE SCLEROSIS 192
A key role for poly(ADP-ribose) polymerase-1 activity during human dendritic cell maturation. 191
Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis: a phase II trial. 186
The TCR Repertoire Reconstitution in Multiple Sclerosis: Comparing One-Shot and Continuous Immunosuppressive Therapies 185
Subgroup Comparison According to Clinical Phenotype and Serostatus in Autoimmune Encephalitis: A Multicenter Retrospective Study 184
Safety and efficacy of autologous hematopoietic stem cell transplantation following natalizumab discontinuation in aggressive Multiple Sclerosis 180
Decrypting the Spectrum of Antigen-Specific T-Cell Responses: The Avidity Repertoire of MBP-Specific T-Cells. 174
Predictors of response to opicinumab in acute optic neuritis 173
Effect of the COVID-19 pandemic on disease activity in multiple sclerosis patients treated with hematopoietic stem cell transplantation 169
T-cell autoimmunity in multiple sclerosis. 169
A whole genome screen for linkage disequilibrium in multiple sclerosis performed in a continental Italian population. 168
SYNTHESIS OF LIPOPEPTIDES OF THE IMMUNODOMINANT EPITOPE HMBP(83-99) CONTAINING AMIDE OR C-C BOND LINKED HYDROPHOBIC CHAINS FOR THE STUDY OF T CELL RESPONSE 167
Seizure recurrence risk after discontinuation of anti-seizure medications: prognostic factors and development of a new predictive scale 166
EFFECT OF LIPOCONJUGATION ON MBP PEPTIDE EPITOPES FOR CD4+ T CELL RESPONSIVENESS 166
Disease reactivation following fingolimod withdrawal in multiple sclerosis: Two case reports. 166
Lipoderivatives of an immunodominant epitope of myelin basic protein increased T cell responsiveness in Lewis rats. 166
Antibodies specific for the lipid-bound form of myelin basic protein during experimental autoimmune encephalomyelitis. 165
Perivenular brain lesions in a primate multiple sclerosis model at 7-tesla magnetic resonance imaging. 165
New approaches to the study of T-cell autoimmunity in multiple sclerosis. 164
[Asn31(N-beta-D-Glucopyranosyl)]hMOG(30-50): an antigen to identify anti-hMOG peptide antibodies in multiple sclerosis patients. 163
Clinical characteristics predicting relapses following disease modifying therapies discontinuation in multiple sclerosis: a monocentric cohort study 162
Amyloid Angiopathy related inflammation and paroxysmal events refractory to anti-seizure therapy: amyloid spells or seizures? 161
Diagnostics of the neuromyelitis optica spectrum disorders (NMOSD). 161
Detection of JCPyV microRNA in blood and urine samples of multiple sclerosis patients under natalizumab therapy. 160
Protein tyrosine phosphatase receptor-type C exon 4 gene mutation distribution in an Italian multiple sclerosis population. 159
Immunohistochemistry analysis of bone marrow biopsies in multiple sclerosis patients undergoing autologous haematopoietic stem cells transplantation 158
MRI analysis of the "central vein sign" allows identification of a subset of relapsing remitting MS patients with brain pathology different from inflammatory demyelination 158
Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: The Italian multi-centre experience 157
A genome screen for multiple sclerosis in Italian families. 156
Neuropsychological assessment in aggressive multiple sclerosis treated with stem cell transplantation 154
Immunosuppressive activity of 13-cis-retinoic acid in rats: aspects of pharmacokinetics and pharmacodynamics. 153
Anti-SARS-Cov2 vaccination at the time of the COVID-19 pandemic: suspected adverse events reporting is the milestone of post-marketing surveillance 153
Safety and tolerability of SARS-Cov-2 vaccination in patients with myasthenia gravis: A multicenter experience 152
Clinical and paraclinical findings in a case series of MOGAD: Exploring the presence of perivenular brain white matter lesions 152
Evaluation of cognitive and language side effects of topiramate in patients with epilepsy, and effectiveness of counseling and speech therapy interventions 152
Spinal cord size as promising biomarker of disability outcomes after hematopoietic stem cell transplantation in multiple sclerosis 151
Long-term-video monitoring EEG and 18F-FDG-PET are useful tools to detect residual disease activity in anti-LGI1-Abs encephalitis: A case report 151
Induction of experimental autoimmune encephalomyelitis in rats and immune response to myelin basic protein in lipid bound form. 150
Autologous Stem Cell Transplantation International Multiple Sclerosis (ASTIMS) trial: a randomised, phase II, controlled, multicentre trial 150
Efficacy of Azathioprine on Multiple Sclerosis new brain lesions evaluated using Magnetic Resonance Imaging. 149
Leptomeningeal enhancement in multiple sclerosis: a focus on patients treated with hematopoietic stem cell transplantation 148
Kynurenine 3-mono-oxygenase activity and neurotoxic kynurenine metabolites increase in the spinal cord of rats with experimental allergic encephalomyelitis. 148
Effects of pixantrone on immune-cell function in the course of acute rat experimental allergic encephalomyelitis. 148
A sequence variation in the MOG gene is involved in Multiple Sclerosis susceptibility in Italy. 148
Multiple sclerosis in twins from continental Italy and Sardinia: A nationwide study. 147
Short-term dynamics of circulating T cell receptor V beta repertoire in relapsing-remitting MS. 147
Central nervous system involvement in systemic lupus erythematosus patients without overt neuropsychiatric manifestations. 147
The affinity spectrum of myelin basic protein reactive T cells. 146
Differences in mesenchymal stem cell cytokine profiles between MS patients and healthy donors: Implication for assessment of disease activity and treatment 146
Effect of disease-modifying treatments on antibody-mediated response to anti- COVID19 vaccination in people with multiple sclerosis 146
HLA-Multiple Sclerosis association in Continental Italy and correlation with disease prevalence in Europe. 145
Short-term evolution of autoreactive T-cell repertoire in multiple sclerosis. 145
Accuracy of the central vein sign evaluation by brain MRI for the pathologic characterization of multiple sclerosis cases with markers of "better explanation" of the diagnosis. 145
Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life. 144
MRI evaluation of the "central vein sign" in brain white matter lesions of multiple sclerosis and systemic autoimmune diseases. 143
Safety and effectiveness of the booster dose of mRNA COVID-19 vaccines in people with multiple sclerosis: A monocentric experience 142
Use of technetium-99m hexamethylpropylene amine oxime single-photon emission tomography for the study of cerebral blood flow reactivity after acetazolamide infusion in patients with Behçet’s disease. 142
Susceptibility weighted MRI can help differentiating pathogenesis of white matter lesions in MS and CNS inflammatory vasculopathies. 141
Prediction of seizure recurrence risk following discontinuation of antiepileptic drugs 141
Multiple sclerosis and Type I diabetes. 140
Severe disease reactivation in two multiple sclerosis patients after natalizumab withdrawal was not halted by monthly administrations of cyclophosphamide - two case reports 140
Totale 19.687
Salva come PNG Salva come JPEG
Categoria #
all - tutte 104.237
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 104.237
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.743 0 0 0 0 152 318 132 256 194 387 100 204
2021/20221.677 55 211 79 117 57 67 65 134 78 70 281 463
2022/20234.386 376 853 221 231 335 769 584 240 489 20 135 133
2023/20241.923 75 236 268 114 161 180 75 352 48 134 178 102
2024/202512.606 518 1.259 798 1.855 3.317 1.812 265 927 542 266 473 574
2025/20267.042 1.613 1.980 1.436 1.502 511 0 0 0 0 0 0 0
Totale 38.999